aTyr Pharma, Inc. (FRA:471A)
Germany
· Delayed Price · Currency is EUR 0.560
+0.050 (9.80%)
At close: Dec 4, 2025
aTyr Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 6.15 | 11.06 | 22.54 | 9.98 | 2.34 | 16.95 | Upgrade
|
| Short-Term Investments | 84.05 | 61.07 | 75.62 | 56.17 | 105.58 | 14.74 | Upgrade
|
| Cash & Short-Term Investments | 90.2 | 72.13 | 98.17 | 66.15 | 107.91 | 31.69 | Upgrade
|
| Cash Growth | 36.70% | -26.53% | 48.41% | -38.70% | 240.53% | 1.75% | Upgrade
|
| Other Receivables | 1.04 | 1.74 | 2.44 | 11.78 | 0.44 | 0.04 | Upgrade
|
| Receivables | 1.04 | 1.74 | 2.44 | 11.78 | 0.44 | 0.04 | Upgrade
|
| Prepaid Expenses | 1.77 | 8.09 | 2.39 | 2.95 | 5.22 | 1.8 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 2 | Upgrade
|
| Total Current Assets | 93.01 | 81.95 | 102.99 | 80.87 | 113.57 | 35.53 | Upgrade
|
| Property, Plant & Equipment | 10.78 | 11.86 | 14.05 | 11.56 | 1.81 | 2.98 | Upgrade
|
| Other Long-Term Assets | 2.86 | 3.02 | 3.62 | 3.36 | 0.16 | 0.21 | Upgrade
|
| Total Assets | 106.65 | 96.83 | 120.65 | 95.79 | 115.54 | 38.73 | Upgrade
|
| Accounts Payable | 4.06 | 4.32 | 3.53 | 3.11 | 1.03 | 1.43 | Upgrade
|
| Accrued Expenses | 10.19 | 9.39 | 11.56 | 9.86 | 4 | 3.57 | Upgrade
|
| Current Portion of Leases | 1.43 | 1.25 | 1.33 | 0.89 | 0.98 | 0.86 | Upgrade
|
| Total Current Liabilities | 15.68 | 14.97 | 16.42 | 13.86 | 6.01 | 5.86 | Upgrade
|
| Long-Term Leases | 10.93 | 12.03 | 13.77 | 10.64 | 0.4 | 1.38 | Upgrade
|
| Total Liabilities | 26.61 | 27 | 30.18 | 24.5 | 6.41 | 7.24 | Upgrade
|
| Common Stock | 0.1 | 0.08 | 0.06 | 0.03 | 0.03 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 672.34 | 602.02 | 558.69 | 489.5 | 481.83 | 370.21 | Upgrade
|
| Retained Earnings | -592.2 | -532.05 | -468.02 | -417.63 | -372.3 | -338.53 | Upgrade
|
| Comprehensive Income & Other | -0 | -0.04 | -0.07 | -0.43 | -0.26 | -0.04 | Upgrade
|
| Total Common Equity | 80.24 | 70.02 | 90.66 | 71.46 | 109.3 | 31.65 | Upgrade
|
| Minority Interest | -0.19 | -0.19 | -0.19 | -0.18 | -0.18 | -0.17 | Upgrade
|
| Shareholders' Equity | 80.04 | 69.83 | 90.47 | 71.28 | 109.13 | 31.48 | Upgrade
|
| Total Liabilities & Equity | 106.65 | 96.83 | 120.65 | 95.79 | 115.54 | 38.73 | Upgrade
|
| Total Debt | 12.36 | 13.28 | 15.1 | 11.53 | 1.38 | 2.24 | Upgrade
|
| Net Cash (Debt) | 77.84 | 58.84 | 83.07 | 54.61 | 106.53 | 29.45 | Upgrade
|
| Net Cash Growth | 48.51% | -29.17% | 52.11% | -48.74% | 261.74% | 51.70% | Upgrade
|
| Net Cash Per Share | 0.87 | 0.79 | 1.55 | 1.92 | 5.58 | 3.21 | Upgrade
|
| Filing Date Shares Outstanding | 97.99 | 88.86 | 67.75 | 53.16 | 27.8 | 16.01 | Upgrade
|
| Total Common Shares Outstanding | 97.99 | 84.04 | 63.29 | 29.5 | 27.79 | 11.02 | Upgrade
|
| Working Capital | 77.34 | 66.99 | 86.58 | 67.01 | 107.56 | 29.67 | Upgrade
|
| Book Value Per Share | 0.82 | 0.83 | 1.43 | 2.42 | 3.93 | 2.87 | Upgrade
|
| Tangible Book Value | 80.24 | 70.02 | 90.66 | 71.46 | 109.3 | 31.65 | Upgrade
|
| Tangible Book Value Per Share | 0.82 | 0.83 | 1.43 | 2.42 | 3.93 | 2.87 | Upgrade
|
| Machinery | - | 3.74 | 4.5 | 5 | 5 | 5.82 | Upgrade
|
| Leasehold Improvements | - | 5.65 | 5.65 | 4.41 | 1.7 | 1.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.